Those who have undergone a liver transplant may not have to fret about using cannabis after the procedure, according to a new study published this month.
The research, published in the journal Clinical Transportation, was based on the examinations of 900 patients. Researchers examined the patients both prior to and after the liver transplantation, ultimately finding “no statistical differences in post-operative outcomes” between cannabis users and non-cannabis users, though the researchers did note “significant differences” elsewhere between the two patient cohorts.
“These findings may help guide future policies regarding marijuana use in [liver transplant] candidates, although confirmation utilizing larger cohorts is warranted,” the researchers wrote in their conclusion, as quoted by NORML.
It is not the first study to suggest that cannabis use does not impose added risks in the event of an organ transplant. All the way back in 2009, in fact, there was a study that found liver transplant patients “who did and did not use marijuana had similar survival rates.”
In 2019, another study found “[n]o significant differences in inpatient respiratory complications, reintubation” in cannabis users and non-cannabis users who had undergone a liver transplant.
“Overall, pretransplant marijuana use, past or current, does not appear to impact
Bud Digest[otw_is sidebar=otw-sidebar-8]